A citation-based method for searching scientific literature

K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
Times Cited: 59



S L Ellis, E G Moser, J K Snell-Bergeon, A S Rodionova, R M Hazenfield, S K Garg. Diabet Med 2011
Times Cited: 88




List of shared articles



Times cited

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes.
Marc Evans, Debbie Hicks, Dipesh Patel, Vinod Patel, Phil McEwan, Umesh Dashora. Diabetes Ther 2020
11

The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.
Kashif M Munir, Stephen N Davis. Expert Opin Pharmacother 2015
11


The efficacy and safety of DPP4 inhibitors in patients with type 1 diabetes: A systematic review and meta-analysis.
Heming Guo, Chen Fang, Yun Huang, Yufang Pei, Linqi Chen, Ji Hu. Diabetes Res Clin Pract 2016
32

Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Marcelo Maia Pinheiro, Caroline Lais Stoppa, Claudete Justina Valduga, Cristina Eunice Okuyama, Renata Gorjão, Regina Mara Silva Pereira, Susana Nogueira Diniz. Eur J Pharm Sci 2017
38

Non-insulin pharmacological therapies for treating type 1 diabetes.
Christian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad, Jens Juul Holst. Expert Opin Pharmacother 2018
4

Using DPP-4 inhibitors to modulate beta cell function in type 1 diabetes and in the treatment of diabetic kidney disease.
Hugh Davis, Vanessa Jones Briscoe, Sofio Dumbadze, Stephen N Davis. Expert Opin Investig Drugs 2019
3

One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin.
Marcos M Lima-Martínez, Ernesto Guerra-Alcalá, Miguel Contreras, José Nastasi, Janelle A Noble, Constantin Polychronakos. Endocrinol Diabetes Metab Case Rep 2014
12

Use of non-insulin therapies for type 1 diabetes.
Satish K Garg, Aaron W Michels, Viral N Shah. Diabetes Technol Ther 2013
8

Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.
Christian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad. Lancet Diabetes Endocrinol 2016
45

Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Susana Nogueira Diniz, Andrea Fabbri, Marco Infante. Int Immunopharmacol 2021
1

Adjunctive therapy for glucose control in patients with type 1 diabetes.
Kira Harris, Cassie Boland, Lisa Meade, Dawn Battise. Diabetes Metab Syndr Obes 2018
8

Current status of metformin in addition to insulin therapy in adult patients with type 1 diabetes mellitus: An analysis from the Guangdong Type 1 Diabetes Mellitus Translational Medicine Study.
Liling Qiu, Ping Ling, Daizhi Yang, Sihui Luo, Xueying Zheng, Hua Liang, Yong Yuan, Ganxiong Liang, Wen Xu, Bin Yao,[...]. J Diabetes 2020
1

Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus.
Jaquellyne Gurgel Penaforte-Saboia, Carlos Eduardo Barra Couri, Natasha Vasconcelos Albuquerque, Vanessa Lauanna Lima Silva, Natália Bitar da Cunha Olegario, Virgínia Oliveira Fernandes, Renan Magalhães Montenegro Junior. Diabetes Metab Syndr Obes 2021
1

DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Qixian Wang, Min Long, Hua Qu, Rufei Shen, Rui Zhang, Jing Xu, Xin Xiong, Hui Wang, Hongting Zheng. J Diabetes Res 2018
19

Preliminary study characterizing the use of sitagliptin for glycemic control in healthy Beagle dogs with normal gluco-homeostasis.
Hitomi Oda, Akihiro Mori, Peter Lee, Kaori Saeki, Toshiro Arai, Toshinori Sako. J Vet Med Sci 2014
0

Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3.
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Margareth Afonso Torres. Endocrinol Diabetes Metab Case Rep 2016
14

Evolving Pharmacotherapeutic Strategies for Type 1 Diabetes Mellitus.
Samie Sabet, Michelle E Condren, Angela F Boston, Lauren C Doak, Laura J Chalmers. J Pediatr Pharmacol Ther 2018
1

Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions.
Shiying Shao, QinQin Xu, Xuefeng Yu, Ruping Pan, Yong Chen. Pharmacol Ther 2020
26




Adjunct therapies in treatment of type 1 diabetes.
Itivrita Goyal, Alamgir Sattar, Megan Johnson, Paresh Dandona. J Diabetes 2020
2

GLP-1 Agonists in Type 1 Diabetes Mellitus.
Kristin M Janzen, Taylor D Steuber, Sarah A Nisly. Ann Pharmacother 2016
15

Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.
Xia Wang, Peilin Zheng, Gan Huang, Lin Yang, Zhiguang Zhou. Clin Exp Med 2018
11